切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2022, Vol. 16 ›› Issue (05) : 522 -525. doi: 10.3877/cma.j.issn.1674-3946.2022.05.015

论著

保乳根治术与全乳房切除术治疗Ⅱ/Ⅲ期乳腺癌的远期生存率随访比较
夏明智1, 刘志华1,(), 徐卫云2   
  1. 1. 410013 长沙,湖南省肿瘤医院乳腺外一科
    2. 621000 四川绵阳,绵阳市中心医院乳腺外科
  • 收稿日期:2021-08-07 出版日期:2022-10-26
  • 通信作者: 刘志华

Long-term survival follow-up of breast-conserving radical mastectomy versus total mastectomy for stage Ⅱ/Ⅲ breast cancer

Mingzhi Xia1, Zhihua Liu1,(), Weiyun Xu2   

  1. 1. Department of Breast Surgery, Hunan Cancer Hospital, Changsha Hunan Province 410013, China
    2. Department of Breast Surgery, Mianyang Central Hospital, Mianyang Sichuan Province 621000, China
  • Received:2021-08-07 Published:2022-10-26
  • Corresponding author: Zhihua Liu
  • Supported by:
    Project of Sichuan Provincial Department of Science and Technology(2018JY0412)
引用本文:

夏明智, 刘志华, 徐卫云. 保乳根治术与全乳房切除术治疗Ⅱ/Ⅲ期乳腺癌的远期生存率随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2022, 16(05): 522-525.

Mingzhi Xia, Zhihua Liu, Weiyun Xu. Long-term survival follow-up of breast-conserving radical mastectomy versus total mastectomy for stage Ⅱ/Ⅲ breast cancer[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2022, 16(05): 522-525.

目的

比较保乳根治术与全乳房切除术治疗Ⅱ/Ⅲ期乳腺癌的远期生存率。

方法

回顾性分析2013年7月至2016年6月137例乳腺癌手术患者临床资料,根据术式不同分为保乳组(n=66例,接受保乳根治术)和全切组(n=71例,接受全乳房切除术)。采用SPSS 23.0统计软件进行数据分析。手术相关指标、心理状态、生活质量等计量资料以(

xˉ
±s)表示,采用独立样本t检验;并发症等计数资料采用χ2检验。采用Kaplan-Meier进行生存分析,利用Log-Rank检验,评估两组患者术后生存情况。P<0.05为差异有统计学意义。

结果

保乳组手术时间高于全切组,患者术中出血量、住院时间低于全切组(P<0.05)。术后保乳组患者焦虑自评量表(SAS)、抑郁自评量表(SDS)评分均低于全切组,健康调查简表(SF-36)评分高于全切组(P<0.05)。两组患者术后并发症总发生率、术后1年、3年、5年复发率和总生存率比较,差异均无统计学意义(P>0.05)。

结论

与全乳房切除术相比,保乳根治术治疗Ⅱ/Ⅲ期乳腺癌具有一定微创优势,可改善患者心理状态,且并未降低患者远期生存率,也未增加并发症风险,值得临床推广,但应严格控制手术适应证。

Objective

To compare the long-term survival rates of breast conserving radical mastectomy and mastectomy for StageⅡ/Ⅲbreast cancer.

Methods

The clinical data of 137 cases of breast cancer from July 2013 to June 2016 were analyzed retrospectively,According to different surgical methods,they were divided into breast conserving group(n=66 cases,undergoing radical mastectomy)and total mastectomy group(n=71 cases,receiving full mastectomy). SPSS 23.0 statistical analysis software was used for data analysis. Operation Related Index,psychological status,quality of life and other measurement data were expressed by(

xˉ
±s),independent sample t test was used,χ2 test was used for counting data of complications. Kaplan-Meier survival analysis and Log-Rank test were used to evaluate the survival of the two groups. P<0.05 was considered statistically significant.

Results

The operation time of breast-conserving group was higher than that of total resection group,and the intraoperative blood loss and hospital stay were lower than those of total resection group(P<0.05). The scores of self-rating Anxiety scale(SAS)and self-rating Depression Scale(SDS)in the breast-conserving group were lower than those in the total resection group,and the health Survey Short Form 36(SF-36)score was higher than that in the total resection group(P<0.05). There was no significant difference in the total incidence of postoperative complications,1,3,5-year recurrence rate and overall survival rate between the two groups(P>0.05).

Conclusion

Compared with mastectomy,breast conserving radical mastectomy for StageⅡ/Ⅲbreast cancer has certain minimally invasive advantages,which can improve patients psychological state,does not reduce patients’ long-term survival rate and does not increase the risk of complications. It is worthy of clinical promotion,but the indication of operation should be strictly controlled.

表1 137例乳腺癌手术不同术式两组患者基线资料比较[(
xˉ
±s),例]
表2 137例乳腺癌手术不同术式两组患者手术相关指标比较(
xˉ
±s)
表3 137例乳腺癌手术不同术式两组患者心理状态及生活质量比较[(
xˉ
±s),分]
表4 137例乳腺癌手术不同术式两组患者并发症比较(例)
表5 137例乳腺癌手术不同术式两组患者远期预后比较[例(%)]
图1 137例乳腺癌手术不同术式两组患者累积生存曲线
[1]
高红霞,齐书山,黄海荣,等. 单孔法腔镜保乳手术治疗早期乳腺癌的疗效观察[J]. 中国肿瘤临床与康复202027(5):80-82.
[2]
张景涵. 乳腺癌女性患者乳腺癌根治术和保乳手术选择意愿调查及影响因素分析[J]. 中国妇幼保健202035(20):3868-3871.
[3]
Lagendijk Mvan Maaren MVSaadatmand S,et al. Breast conserving therapy and mastectomy revisited:Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients[J]. Int J Cancer2018142(1):165-175.
[4]
沈钧华,包小平,马元勇. 前哨淋巴结活检联合保乳术与根治术治疗乳腺癌的临床疗效观察[J]. 山西医药杂志202150(3):433-435.
[5]
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J]. 中国癌症杂志201929(8):609-680.
[6]
王露,杨卫兵,孙小婕,等. 环乳晕入路保留乳头乳晕乳腺癌改良根治术的应用效果[J]. 实用癌症杂志201833(10):1700-1703.
[7]
施丽娜,费杨虹虹,司婷婷,等. 保乳手术和根治性手术治疗乳腺癌的疗效及对患者神经降压素和神经降压素受体1的影响[J].中国妇幼保健202136(9):2175-2178.
[8]
唐小乔,苏磊,桑剑锋. 乳腺癌改良根治术后上肢淋巴水肿与腋窝淋巴结阳性率的相关性分析[J/CD]. 中华普外科手术学杂志(电子版)202014(1):74-77.
[9]
Chen RYou SYin Z,et al. Non-doctoral factors influencing the surgical choice of Chinese patients with breast cancer who were eligible for breast-conserving surgery[J]. World J Surg Oncol201917(1):189.
[10]
Mátrai ZUjhelyi MKovacs T,et al. Evaluation of a Retroglandular Oncoplastic Technique as a Standard Level I Oncoplastic Breast-Conserving Surgery:A Retrospective Clinicopathologic Study of 102 Patients With Breast Cancer[J]. Clin Breast Cancer201919(3):e459-e467.
[11]
李敬显,杨雷坤. 保留乳头乳晕的乳腺癌改良根治术治疗乳腺癌的效果[J]. 临床医学研究与实践20205(12):83-84.
[12]
Qiu HXu WHKong J,et al. Effect of breast-conserving surgery and modified radical mastectomy on operation index,symptom checklist-90 score and prognosis in patients with early breast cancer[J]. Medicine202099(11):e19279.
[13]
潘艳霞. 早期乳腺癌保乳术中应用肿瘤整形技术的效果[J]. 中国实用医刊202047(2):81-83.
[14]
Van den Broek AJSchmidt MKVan’t Veer LJ,et al. Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients[J]. Ann Surg2019270(2):364-372.
[15]
杜彦秋,管霞,常登峰,等. 基于Bevilacqua模型的乳腺癌保乳术患者术后淋巴水肿风险预测的临床研究[J/CD]. 中华普外科手术学杂志(电子版)202115(1):53-56.
[16]
林明,王睿琳. 改良根治术与早期乳腺癌保乳手术的疗效及对患者创伤后应激障碍发生的影响[J]. 实用癌症杂志202136(3):475-478.
[17]
张扬,杨飏,王歆光,等. 保乳术联合术中放疗治疗早期乳腺癌的近期疗效及安全性[J]. 中华肿瘤杂志202042(8):682-686.
[18]
刘峥,杨基鹏,任思媛,等. 保留乳头的乳腺癌切除术在早期乳腺癌患者中临床效果研究[J/CD]. 中华普外科手术学杂志(电子版)202014(3):273-276.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[3] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[4] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[5] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[6] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[7] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[8] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[9] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[10] 葛睿, 陈飞, 李杰, 李娟娟, 陈涵. 多基因检测在早期乳腺癌辅助治疗中的应用价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 257-263.
[11] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[12] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[13] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[14] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[15] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
阅读次数
全文


摘要